Standard Article

Cyclic Nucleotides and Blood Vessel Contraction

Handbook of Physiology, The Cardiovascular System, Vascular Smooth Muscle

  1. George L. Kramer1,
  2. Joel G. Hardman2

Published Online: 1 JAN 2011

DOI: 10.1002/cphy.cp020208

Comprehensive Physiology

Comprehensive Physiology

How to Cite

Kramer, G. L. and Hardman, J. G. 2011. Cyclic Nucleotides and Blood Vessel Contraction. Comprehensive Physiology. 179–199.

Author Information

  1. 1

    Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

  2. 2

    Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

Publication History

  1. Published Online: 1 JAN 2011

Abstract

The sections in this article are:

  • 1
    Effects of Vasoactive Agents on Cyclic Nucleotide Levels
  • 2
    Effects of Externally Applied Cyclic Nucleotides
  • 3
    Adenylate and Guanylate Cyclases
  • 4
    Cyclic Nucleotide Phosphodiesterases and Phosphodiesterase Inhibitors
    • 4.1
      Distribution
    • 4.2
      Multiple Forms of Phosphodiesterase
    • 4.3
      Inhibitors
    • 4.4
      Comparative Studies in Hypertensive Rats
  • 5
    Cyclic Nucleotide-Dependent Protein Kinases
  • 6
    Interactions Between Cyclic Nucleotides and Ca2+
  • 7
    Conclusion